NMTC News and Press, NeuroOne Medical Technologies Corporation From 08/11/22

NeuroOne Medical Technologies Corporation press release ( NASDAQ: NMTC ): Q3 Net Loss of $2.8M Product revenue of $0.03M As of June 30, 2022, the Company had cash of approximately $10.2 million, compared to $6.9 million as of September 30, 2021, the end of the Company'...

NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update PR Newswire EDEN PRAIRIE, Minn. , Aug. 11, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a...

NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode PR Newswire Company re-submits application to gain FDA clearance for less than 30 day use EDEN PRAIRIE, Minn. , Aug. 9, 2022 /PRNewswire/ -- NeuroOne Medical Technologi...

NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11 PR Newswire EDEN PRAIRIE, Minn. , Aug. 4, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical te...

Gainers: Kaspien Holdings ( KSPN ) +136% . Heart Test Laboratories ( HSCS ) +92% . Poseida Therapeutics ( PSTX ) +74% . Eargo ( EAR ) +73% . Ping Identity ( PING ) +60% . Applied DNA ( APDN ) +53% . Golden Sun ( ...

NeuroOne Medical Technologies ( NASDAQ: NMTC ) entered into an amendment to its Exclusive Development and Distribution Agreement with Zimmer Biomet ( NYSE: ZBH ) providing the company with a $3.5M accelerated payment within 10 business days which relates to certai...

Gainers: Applied DNA Sciences ( APDN ) +93% . Alnylam Pharmaceuticals ALNY +55% . Poseida Therapeutics PSTX +47% . NeuroOne Medical Technologies ( NMTC ) +31% . Sonoma Pharmaceuticals ( SNOA ) +21% . Losers: BridgeBio Pharma B...

NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode PR Newswire Amendment provides Zimmer Biomet with 350,000 warrants with exercise price of $3.00 per share EDEN PRAIRIE, Minn. , Aug...

Applied DNA Sciences ( APDN ) +116% . Poseida Therapeutics ( PSTX ) +81% . Ping Identity Holding ( PING ) +60% Non-GAAP EPS of -$0.34 misses by $0.22, revenue of $72.03M misses by $1.27M. Alnylam Pharmaceuticals ( ALNY ) +47% as Phase 3 tr...

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode PR Newswire Case performed at Emory University for intraoperative brain mapping EDEN PRAIRIE, Minn. , July 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corpo...